EGFR and non-small cell lung carcinoma: The median PFS was 16.3 months (95% CI: 15.6–16.9) and 11.1 months (95% CI: 7.2–15.0) for common EGFR mutation-positive NSCLC and uncommon EGFR mutation-positive NSCLC, respectively (Figure S1A) (p < 0.001).